Linkers in bitopic agonists shape bias profile among transducers for the dopamine D2 and D3 receptors

Ana Semeano,Rian Garland,Alessandro Bonifazi,Kuo Hao Lee,John Famiglietti,Wenqi Zhang,Yoon Jae Jo,Francisco O. Battiti,Lei Shi,Amy Hauck Newman,Hideaki Yano
DOI: https://doi.org/10.1101/2024.01.07.574547
2024-01-08
Abstract:Bitopic ligands bind both orthosteric and allosteric or secondary binding sites within the same receptor, often resulting in improvement of receptor selectivity, potency, and efficacy. In particular, for both agonists and antagonists of the dopamine D2 and D3 receptors (D2R and D3R), the primary therapeutic targets for several neurological and neuropsychiatric disorders, bitopic ligand design has proved advantageous in achieving better pharmacological profiles . Although the two pharmacophores within a bitopic ligand are typically considered the main drivers of conformational change for a receptor, the role of the linker that connects the two has not yet been systematically studied for its relevance in receptor activity profiles. Here, we present a comprehensive analysis of sumanirole and PF592,379-based indole-containing bitopic compounds in agonist activity at D2R and D3R, with a focus on linker chemical space and stereochemistry achieved through testing seven distinct chirally resolved linkers. The current study examines the structure activity relationships (SAR) of these linkers extensively, beyond the conventional level, by characterizing activation of all putative transducers over a 44 min time course. Our multiparametric analysis provides previously unappreciated clarity of linker-dependent effects, highlighting the utility of this applied comprehensive approach and the significance of linker type in the shaping of transducer bias profiles.
Pharmacology and Toxicology
What problem does this paper attempt to address?